- Home
- QUAD vs EYPT Comparison
QUAD vs EYPT Comparison
Compare QUAD & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QUAD
- EYPT
- Stock Information
- Founded
- QUAD 1971
- EYPT 1987
- Country
- QUAD United States
- EYPT United States
- Employees
- QUAD N/A
- EYPT N/A
- Industry
- QUAD Publishing
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- QUAD Consumer Discretionary
- EYPT Industrials
- Exchange
- QUAD Nasdaq
- EYPT Nasdaq
- Market Cap
- QUAD 408.6M
- EYPT 489.4M
- IPO Year
- QUAD 2010
- EYPT 2005
- Fundamental
- Price
- QUAD $6.00
- EYPT $6.15
- Analyst Decision
- QUAD Strong Buy
- EYPT Strong Buy
- Analyst Count
- QUAD 2
- EYPT 8
- Target Price
- QUAD $10.15
- EYPT $25.71
- AVG Volume (30 Days)
- QUAD 335.2K
- EYPT 886.1K
- Earning Date
- QUAD 02-18-2025
- EYPT 03-06-2025
- Dividend Yield
- QUAD 3.76%
- EYPT N/A
- EPS Growth
- QUAD N/A
- EYPT N/A
- EPS
- QUAD N/A
- EYPT N/A
- Revenue
- QUAD $2,672,200,000.00
- EYPT $45,713,000.00
- Revenue This Year
- QUAD N/A
- EYPT N/A
- Revenue Next Year
- QUAD N/A
- EYPT N/A
- P/E Ratio
- QUAD N/A
- EYPT N/A
- Revenue Growth
- QUAD N/A
- EYPT 7.50
- 52 Week Low
- QUAD $4.06
- EYPT $5.90
- 52 Week High
- QUAD $9.13
- EYPT $29.31
- Technical
- Relative Strength Index (RSI)
- QUAD 40.04
- EYPT 36.22
- Support Level
- QUAD $6.57
- EYPT $5.90
- Resistance Level
- QUAD $8.04
- EYPT $6.67
- Average True Range (ATR)
- QUAD 0.64
- EYPT 0.71
- MACD
- QUAD -0.06
- EYPT -0.04
- Stochastic Oscillator
- QUAD 1.92
- EYPT 8.99
About QUAD Quad Graphics Inc
Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.